Dear Editor
Vitamin D deficiency or insufficiency affects about 30% of children and 60% of adults across the world (1) . This condition also occurs in about 70% of critically ill patients (2) . Although vitamin D is typically known as a fat-soluble vitamin in bone metabolism, it is a steroid hormone with pleiotropic effects (3) . Vitamin D deficiency can lead to cardiovascular, neurological, and autoimmune diseases and different types of cancers, including the breast, prostate, lung, colon, and renal cancers. Accordingly, this deficiency has a direct correlation with mortality (4-6).
Many critically ill patients enter the Intensive Care Unit (ICU) with a deficient level of vitamin D. Disrupted metabolism of vitamin D in some critically ill patients results in a fast decrease in vitamin D levels after ICU admission (7) . It has been well documented that vitamin D deficiency is associated with increased morbidity, mortality, and ICU length of stay (8, 9) . The randomized clinical trials having been performed in recent years are indicative of no significant improvement in the clinical outcome of critically ill patients supplemented with vitamin D (10).
The ICU admission can be predicted in several conditions, such as some elective surgeries and intensive chemotherapies (7) . Furthermore, one of the problems of the studies performed till now is that they have not exclusively investigated the patients with vitamin D deficiency. However, the exclusive inclusion of patients with vitamin D deficiency can lower the sample size for a clinical trial.
It is required to perform randomized clinical trials with a reasonable sample size to investigate the effect of vitamin D supplementation among vitamin D deficient patients who are in a critical medical state. These studies will be useful for the better conceptualization of treatment with vitamin D in critically ill patients.
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